Ionis Pharmaceuticals announces private placement of $507.5 million principal amount of 0.125% convertible senior notes due 2024
- Thursday, December 12, 2019, 7:21
- Business
- Add a comment
CARLSBAD, Calif., Dec. 12, 2019 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (“Ionis”) announced today that it has entered into privately negotiated exchange and/or subscription agreements, with certain holders of its outstanding 1.00% Convertible Senior Notes due 2021 (the…
About the Author
adminasapcorp has written 42188 stories on this site.